The U.S. Food and Drug Administration (FDA) has granted traditional full approval to the CAR-T cell therapy Tecartus ...
Dr. Coleman: For patients with recurrent ovarian cancer, the main benefit of adding Lifyorli to nab-paclitaxel is controlling ...
A study led by researchers at a community hospital in Sapporo, Japan found that comprehensive genomic testing using a ...
Author and survivor Parul Somani shares how patients with breast cancer can find peace of mind when clinical certainty is ...
That choice was not available to me. My perspective on genetic risk isn't theoretical. My mother, Ioanna, died when I was 9.
The study's safety findings suggest that the physical "number" of a patient's age is less important than their functional ...
FDA NDA submission for bezuclastinib targets post-imatinib GIST, using Real-Time Oncology Review and supported by prior ...
New ELCC 2026 data show longer survival, better brain metastases control and more personalized treatment options for patients ...
U.S. Food and Drug Administration (FDA) has approved a PD-L1 companion diagnostic test for patients with esophageal cancer or ...
CTIM-76 has received FDA fast track designation for platinum-resistant ovarian cancer, a step aimed at accelerating ...
A kidney cancer survivor shares how a decade of breakthroughs in immunotherapy and targeted research transformed a death ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results